Skip to main content
. Author manuscript; available in PMC: 2009 Apr 1.
Published in final edited form as: Integr Comp Biol. 2006 Dec 1;46(6):1072–1081. doi: 10.1093/icb/icl041

Fig. 1.

Fig. 1

Growth inhibitory activity of epigonal conditioned medium against cell lines of various tumor origins. (A) WEHI 164 (fibrosarcoma), N = 9; (B) A375.S2 (malignant melanoma), N = 26; (C) NIH:OVCAR-3 (ovarian carcinoma), N = 11; (D) PANC-1 (pancreatic carcinoma), N = 7; (E) Jurkat (T-cell leukemia), N = 4; (F) Daudi (B-cell lymphoma), N = 3; (G) MCF7 (breast carcinoma), N = 18.